Table 2 Analysis of the impact of ALC levels at different time periods on patient prognosis.
Index | N | OS rate (%) | X2 | P | PFS rate (%) | X2 | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
1 year | 2 year | 3 year | 1 year | 2 year | 3 year | ||||||
Baseline ALC | 0.335 | 0.563 | 0.281 | 0.596 | |||||||
Low | 57 | 81.9 | 62.9 | 52.6 | 56.8 | 30.1 | 23.9 | ||||
Medium + High | 22 | 95.5 | 61.5 | 61.5 | 77.3 | 31.2 | 31.2 | ||||
Mid-treatment ALC | 10.939 | 0.004 | 8.472 | 0.014 | |||||||
Low | 31 | 96.3 | 83.5 | 74.7 | 79.5 | 48.8 | 40.3 | ||||
Medium | 31 | 90.1 | 58.7 | 50.3 | 58.1 | 19.9 | 19.9 | ||||
High | 17 | 58.8 | 35.3 | 35.3 | 41.2 | 17.6 | 17.6 | ||||
Post-treatment ALC | 8.778 | 0.012 | 12.949 | 0.002 | |||||||
Low | 27 | 96.3 | 77.7 | 72.8 | 77.4 | 52.1 | 46.9 | ||||
Medium | 36 | 83.3 | 62.9 | 53.0 | 60.7 | 24.3 | 20.9 | ||||
High | 16 | 72.9 | 32.8 | 32.7 | 41.7 | 6.9 | 6.9 | ||||
